Fingerprint
Dive into the research topics of 'Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically